Volume 87, Issue 3, 2022-9-1, Pages A9-e120

Articles in this issue:

1. Editorial Board

2. Table of Contents

3. Information for Readers

4. JAAD Case Reports Article List

5. Journal Based CME Instructions and Information

6. Cutaneous manifestations of child abuse and neglect: Part I

7. Cutaneous mimics of child abuse and neglect: Part II

8. Letter from the Editor: Delays in melanoma diagnosis

9. This Month in JAAD: September 2022

10. This month in JAAD Case Reports: September 2022. Isotretinoin for idiopathic facial aseptic granuloma

11. This Month in JAAD International: September 2022: The burden of skin disease among Central American agricultural workers

12. The criteria-dependent risk of systemic lupus erythematosus developing in patients with discoid lupus erythematosus

13. DESCRIBE-AD: A novel classification framework for atopic dermatitis

14. Dermatoscopic and clinical features of congenital or congenital-type nail matrix nevi: A multicenter prospective cohort study by the International Dermoscopy Society

15. Cross-sectional characteristics of pediatric-onset discoid lupus erythematosus: Results of a multicenter, retrospective cohort study

16. Melanoma with peripheral globules: Clinical and dermatoscopic features

17. Development of a core outcome set for basal cell carcinoma

18. Longitudinal course and predictors of depressive symptoms in atopic dermatitis

19. A comparison of invasive squamous cell carcinoma greater than 1 year after treatment with 5-fluorouracil, imiquimod, or photodynamic therapy with aminolevulinic acid

20. Cutaneous manifestations of chimeric antigen receptor T-cell therapy: An introduction for dermatologists

21. BRAF inhibition and the spectrum of granulomatous reactions

22. Red scrotum syndrome: An update on clinicopathologic features, pathogenesis, diagnosis, and management

23. Review of transition of care literature: Epidermolysis bullosa—A paradigm for patients with complex dermatologic conditions

24. Clinical presentation and management of atypical and recalcitrant acute generalized exanthematous pustulosis

25. The evaluation and management of macronutrient deficiency dermatoses

26. The association between COVID-19 lockdowns and melanoma diagnosis and thickness: A multicenter retrospective study from Europe

27. Risk of herpes zoster reactivation after messenger RNA COVID-19 vaccination: A cohort study

28. Histologic subtype of cutaneous immune-related adverse events predicts overall survival in patients receiving immune checkpoint inhibitors

29. Dermatologic management of ocular mucous membrane (cicatricial) pemphigoid with mycophenolate mofetil in 38 patients

30. Clinical manifestations and treatment outcomes of pyoderma gangrenosum following rituximab exposure: A systematic review

31. Practical guide to tinted sunscreens

32. The effect of biologic therapy for immune-mediated inflammatory diseases on clinical outcomes of COVID-19 in the greater Houston area: A retrospective chart review

33. Psoriasis flares and rebound phenomenon following exposure and withdrawal of systemic steroids: A systematic review and meta-analysis

34. Topical timolol enhances surgical wound healing in the lower portion of the leg in older patients with comorbidities: A retrospective review

35. Treatment of lichen planopilaris with baricitinib: A retrospective study

36. Refractory folliculitis decalvans treated with adalimumab: A case series of 23 patients

37. Lifestyle risk factor counseling at visits for psoriasis and psoriatic arthritis in the United States

38. Therapeutic efficacy of topical imiquimod cream on keratoacanthoma: A retrospective single-center study

39. Alexandrite laser as an adjuvant therapy in the management of mild to moderate hidradenitis suppurativa: A controlled prospective clinical study

40. Volume and distribution of skin biopsies performed by dermatologists and other health care providers in the Medicare population in 2019

41. Pediatric teledermatology: A retrospective review of 1199 encounters during the COVID-19 pandemic

42. Efficacy and safety of ustekinumab in Behçet disease: Results from the prospective phase 2 STELABEC trial

43. Trends in the prescribing pattern of spironolactone for acne and hidradenitis suppurativa in adolescents

44. Prevalence of lichen planus in the United States: A cross-sectional study of the All of Us research program

45. Acne and insulin resistance: A systematic review and meta-analysis

46. Evaluating the longitudinal course of atopic dermatitis: A review of the literature

47. Increased risk of vitamin D deficiency and insufficiency in Black patients with central centrifugal cicatricial alopecia

48. Association of atopic dermatitis with attention-deficit hyperactivity disorder among US adults in the “All of Us” research program: A case-control study

49. Diagnostic testing of eczematous dermatitis with incomplete response to dupilumab

50. Not all well-differentiated cutaneous squamous cell carcinomas are equal: Tumors with disparate biologic behavior have differences in protein expression via digital spatial profiling

51. A stepwise approach for the management of primary erythromelalgia: A prospective single-arm study

52. Low-dose oral minoxidil for treatment of androgenetic alopecia and telogen effluvium in a pediatric population: A descriptive study

53. Genetic liability to acne is associated with increased risk of inflammatory bowel disease: A Mendelian randomization study

54. A prospective pilot study of narrowband UV-B treatment of lichen planopilaris

55. Secukinumab is effective in the treatment of recalcitrant palmoplantar psoriasis and palmoplantar pustular psoriasis in a daily practice setting

56. Pemphigus vulgaris after COVID-19 infection and vaccination

57. Prevalence of SARS-CoV-2 infection in asymptomatic preoperative patients scheduled for dermatologic surgery: A single-center retrospective chart review

58. Predictors of COVID-19 disease severity augment the Braden scale in the prediction of pressure ulcer development among COVID-19–positive intensive care unit patients: A case-control study

59. Psoriatic lesional expression of SARS-CoV-2 receptor ACE2 is reduced by blockade of IL-17 signaling but not by other biologic treatments

60. Association of psoriasis with risk of COVID-19: A 2-sample Mendelian randomization study

61. Comparison of patient demographics at a free clinic prior to versus during the COVID-19 pandemic

62. Ethics of antibiotic stewardship in dermatology

63. JAAD Game Changers∗: Squamous cell carcinoma with aggressive subclinical extension: 5-year retrospective review of diagnostic predictors

64. Using medical Vaseline gauze to alleviate the pressure injury caused by a mask and hat

65. The novel application of a tourniquet for reducing medical device–related pressure on the ears

66. Segmental excision of congenital melanocytic nevus by multiple incisions

67. Management of postoperative bleeding after use of a retroauricular interpolation flap

68. A novel strategy for repairing middle upper lip defects: Bullhead flap

69. Evaluation of the external auditory canal

70. Localized verrucous venous malformations: Treatment and response evaluation

71. Authors’ reply: Intralesional bleomycin injection for localized verrucous venous malformations

72. Response to Chen et al’s “Tonsillectomy and the Subsequent Risk of Psoriasis: A Nationwide Population-Based Cohort Study”

73. Understanding racial disparities in prurigo nodularis

74. Response to: “Racial disparities in mortality among patients with prurigo nodularis: A multi-center cohort study”

75. From the Cochrane library: Interventions for melanoma in situ, including lentigo maligna

76. Correspondence on the article “Epicardial adipose tissue volume is greater in men with severe psoriasis, implying an increased cardiovascular disease risk: A cross-sectional study” by Ellis et al

77. Psychiatric comorbidities associated with granuloma annulare: A case-control study in the All of Us database